Adagene Inc ADAG:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/02/21 EST
24.56quote price arrow down-0.42 (-1.68%)
Volume
14,454
52 week range
20.21 - 31.83

...

Loading . . .

KEY STATS

  • Open24.97
  • Day High24.97
  • Day Low23.99
  • Prev Close24.56
  • 52 Week High31.83
  • 52 Week High Date02/11/21
  • 52 Week Low20.21
  • 52 Week Low Date02/09/21
  • Market Cap828.65M
  • Shares Out33.74M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.40
  • P/E (TTM)-62.11
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-35.229M
  • ROE (MRQ)-
  • Revenue (MRQ)790,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-4,337.35%
  • Debt To Equity (MRQ)8.32%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Adagene Inc News

There is no recent news for this security.

Latest ADAG News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. The Company is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the...
Address
Suzhou, JNG
215123
China